Arkolith/Insider Trading/TRDA/Form 4

Parmar Kush

Director, 10% OwnerEntrada Therapeutics, Inc. (TRDA) · full profile →Form 4 · filed Nov 18, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.8M
Net Open-Market Flow
-$1.8M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 14, 2025Sell(S)200K$8.80$1.8M3.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001664281-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML